Disclosure: Dr MJ Barry is President of the Informed Medical Decisions Foundation, a part of
Healthwise, where he is also Chief Science Officer. Healthwise is a 501 (c) 3 nonprofit …

Patients who are diagnosed with localized prostate cancer need to make critical treatment
decisions that are sensitive to their values and preferences. The role of decision aids in …

BACKGROUND The 5‐year relative survival for prostate cancers diagnosed between 1990
and 1994 in the United States was very high (92%); however, survival in black males was …

Purpose To determine the demographic, clinical, decision-making, and quality-of-life factors
that are associated with treatment decision regret among long-term survivors of localized …

BACKGROUND. Commercial gene expression assays are guiding clinical decision making
in patients with prostate cancer, particularly when considering active surveillance. Given …

Purpose We determined the incidence of pathological upgrading and up staging for
contemporary, clinically low risk patients, and identified predictors of having occult …

This article is a review of approaches to treatment of low and high-grade prostate cancer
including a discussion of active treatment vs. active surveillance for patients with low-grade …

Background Magnetic resonance imaging–guided transurethral ultrasound ablation (MRI-
TULSA) is a novel minimally invasive technology for ablating prostate tissue, potentially …

Purpose: Anxiety may serve as a major barrier to participation in active surveillance.
Intolerance of uncertainty, that is the tendency to perceive the potential for negative events …

Answer questions and earn CME/CNE Since the dissemination of prostate‐specific antigen
screening, most men with prostate cancer are now diagnosed with localized, low‐risk …